The most robust clinical evidence for the effectiveness of the monkeypox virus (MPX) vaccine was published today by the U.K. Health Security Agency (UKHSA).
The UKHSA estimates that the two-dose JYNNEOS® (MVA-BN, IMVAMUNE®) vaccine effectiveness for a single dose was 78% fourteen or more days after the initial vaccination.
Read More
